SynbioVen

SynbioVen SynbioVen was created in 2022 as the UK's dedicated investment vehicle for synthetic biology. a focused bet that synbio would become a major technology platform and that the UK, with its strong academic base, needed a purpose-built funding mechanism. The fund is relatively modest at £20M total, with £15M earmarked for proof-of-concept through seed-stage synbio startups. But the real story is the infrastructure play: SynbioVen has an official partnership with Imperial College London's